Michael A Gara
Overview
Explore the profile of Michael A Gara including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
30
Citations
598
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Dobkin R, Mann S, Weintraub D, Rodriguez K, Miller R, St Hill L, et al.
Mov Disord
. 2021 Mar;
36(11):2549-2558.
PMID: 33710659
Background: For several decades, a myriad of factors have contributed to the inadequate diagnosis and management of depression in Parkinson's disease (PD), leaving up to 60% of significantly symptomatic patients...
2.
Dobkin R, Mann S, Gara M, Interian A, Rodriguez K, Menza M
Neurology
. 2020 Apr;
94(16):e1764-e1773.
PMID: 32238507
Objective: To determine whether, for patients with depression and Parkinson disease (PD), telephone-based cognitive-behavioral treatment (T-CBT) alleviates depressive symptoms significantly more than treatment as usual (TAU), we conducted a randomized...
3.
Interian A, Myers C, Chesin M, Kline A, St Hill L, King A, et al.
Psychiatry Res
. 2019 Nov;
287:112624.
PMID: 31727438
Neurocognitive detection of suicidal states has the potential to significantly advance objective risk assessment. This goal requires establishing that neurocognitive deficits fluctuate around the time of a suicide attempt. The...
4.
Cognitive behavioral therapy improves diverse profiles of depressive symptoms in Parkinson's disease
Dobkin R, Mann S, Interian A, Gara M, Menza M
Int J Geriatr Psychiatry
. 2019 Feb;
34(5):722-729.
PMID: 30714202
Objective: Depression is among the most common and debilitating nonmotor complaints in Parkinson's disease (PD), yet there is a paucity of controlled research to guide treatment. Little research has focused...
5.
Gara M, Minsky S, Silverstein S, Miskimen T, Strakowski S
Psychiatr Serv
. 2018 Dec;
70(2):130-134.
PMID: 30526340
Objective: The authors examined electronic medical record (EMR) outpatient data to determine whether African Americans with schizophrenia or schizoaffective disorder were more likely than non-Latino whites to screen positive for...
6.
Dobkin R, Interian A, Durland J, Gara M, Menza M
J Geriatr Psychiatry Neurol
. 2018 Jun;
31(4):171-176.
PMID: 29945467
High rates of depression are observed in Parkinson's disease, and limited access to care complicates management. The purpose of this pilot project was to evaluate the feasibility and impact of...
7.
Gara M, Rosenberg S, Cohen B
Psychiatry
. 2016 Oct;
50(3):267-279.
PMID: 27719441
No abstract available.
8.
Joseph J, Gara M, Silverstein S
Schizophr Res Cogn
. 2015 Sep;
2(2):56-63.
PMID: 26346124
The power of SNP association studies to detect valid relationships with clinical phenotypes in schizophrenia is largely limited by the number of SNPs selected and non-specificity of phenotypes. To address...
9.
Feigenson K, Gara M, Roche M, Silverstein S
Psychiatry Res
. 2014 Mar;
217(1-2):1-8.
PMID: 24656898
A subgroup of people with schizophrenia is characterized by reduced organization in perception, thought, language, and motor functioning, and these impairments covary significantly. While this may reflect multiple expressions of...
10.
Dobkin R, Troster A, Rubino J, Allen L, Gara M, Mark M, et al.
J Neuropsychiatry Clin Neurosci
. 2013 Nov;
26(1):57-63.
PMID: 24275895
The authors describe neuropsychological outcomes in people with Parkinson's disease (PD) after their participation in an NIH-sponsored, randomized, controlled trial of cognitive-behavioral treatment for depression. Improvements in mood were associated...